Caporali, Roberto, Roberto Ravasio, Paola Raimondo, and Fausto Salaffi. 2021. “Cost Per Responder for Upadacitinib Vs Abatacept in Patients With Moderate-to-Severe Rheumatoid Arthritis in Italy”. Global and Regional Health Technology Assessment 8 (1):69-79. https://doi.org/10.33393/grhta.2021.2267.